Market Overview

'All Timing': Citron Covers Helios And Matheson Short

'All Timing': Citron Covers Helios And Matheson Short
Related HMNY
Helios And Matheson Again Warns There's 'Substantial Doubt' It'll Be In Business Next Summer Without More Cash
MoviePass Walks Back Subscription Price Hike, Limits Customers To 3 Movies Per Month
Technology - Top 5 Gainers / Losers as of 3.00 PM (09/17/2018) (Seeking Alpha)

That was quick.

A day after calling out Helios and Matheson Analytics Inc (NASDAQ: HMNY) following its massive run, Citron Research has covered its short position.

At time of publication, Helios and Matheson traded at $22.39, down 31 percent. It had hit an intraday low of $20.60.

See Also: Citron Goes After Analytics Company Up 1,000% In A Month

Helios had risen more 1,000 percent than since Sept. 14 reports of significant MoviePass subscription growth. Citron on Wednesday set a $20 target on the stock.

While Helios and Matheson actually closed 18 percent higher Wednesday, it's had a brutal Thursday, following reports of an increased stake in MoviePass — a $1.5 million investment bringing ownership from 53 percent to 53.7 percent. As Benzinga's Elizabeth Balboa pointed out, "investors, perhaps mindful of the 40-percent downside predicted by Andrew Left, soon saw an opportunity to cash out."

A short "will be profitable if the short position is covered at a lower price than the stock was sold short. It would result in a loss if the short covering occurs at a higher price than the stock was shorted."


Posted-In: Andrew Left Citron Citron ResearchLong Ideas Short Sellers Short Ideas Movers Trading Ideas Best of Benzinga


Related Articles (HMNY)

View Comments and Join the Discussion!

4 Biotech Stocks Initiated At Buy: Acceleron, Tesaro, Mirati, Fate

Production Delays In Asia Weighing On Under Armour's Curry 4 Release